West Pharmaceutical Services Announces Leadership Changes
Ticker: WST · Form: 8-K · Filed: Apr 14, 2025 · CIK: 105770
Sentiment: neutral
Topics: leadership-change, executive-appointment, board-composition
TL;DR
West Pharma's CFO is changing, new director appointed, and a board member resigned.
AI Summary
On April 9, 2025, West Pharmaceutical Services, Inc. reported a departure of a director, Mr. David L. Johnson, who resigned from the Board of Directors. The company also announced the election of Ms. R. Sarah Keohane as a new director and the appointment of Mr. Kevin J. Cannon as Chief Financial Officer, effective April 15, 2025. Additionally, the company disclosed compensatory arrangements for certain officers.
Why It Matters
Changes in key leadership positions like CFO and board composition can signal shifts in company strategy or financial oversight, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Leadership changes, especially the CFO role, can introduce uncertainty and potential strategic shifts, warranting closer monitoring by investors.
Key Players & Entities
- West Pharmaceutical Services, Inc. (company) — Registrant
- David L. Johnson (person) — Departing Director
- R. Sarah Keohane (person) — Newly Elected Director
- Kevin J. Cannon (person) — Appointed Chief Financial Officer
- April 9, 2025 (date) — Date of earliest event reported
- April 15, 2025 (date) — Effective date for CFO appointment
FAQ
Who has resigned from the Board of Directors?
Mr. David L. Johnson has resigned from the Board of Directors.
Who has been elected as a new director?
Ms. R. Sarah Keohane has been elected as a new director.
Who has been appointed as the new Chief Financial Officer?
Mr. Kevin J. Cannon has been appointed as the new Chief Financial Officer.
When is the appointment of the new CFO effective?
The appointment of Mr. Kevin J. Cannon as Chief Financial Officer is effective April 15, 2025.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported is April 9, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 14, 2025 by David L. Johnson regarding WEST PHARMACEUTICAL SERVICES INC (WST).